Mutations of epidermal growth factor receptor and K-ras genes in adenosquamous carcinoma of the lung [6]

International Journal of Cancer

Volumn 118, Issue 6, 2006, Pages 1588-1590

  Toyooka, Shinichi ^a   Yatabe, Yasushi ^b   Tokumo, Masaki ^a   Ichimura, Kouichi ^a   Asano, Hiroaki ^a   Tomii, Kunitoshi ^a   Aoe, Motoi ^a   Yanai, Hiroyuki ^a   Date, Hiroshi ^a   Mitsudomi, Tetsuya ^b   Shimizu, Nobuyoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; CLINICAL ARTICLE; DEVELOPED COUNTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MALE; MICRODISSECTION; ONCOGENE K RAS; PRIORITY JOURNAL; SOMATIC MUTATION;

AGED; BASE SEQUENCE; CARCINOMA, ADENOSQUAMOUS; CLONE CELLS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33644502521     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21500     Document Type: Letter

References (14)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl 8):4-66.
2. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002;64:681-708.
3. Travis WD, Branbilla E, Muller-Hermelink HK, Harris HH. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC, 2004. 10-52.
4. Toyooka S, Toyooka KO, Maruyama R, Virmani AK, Girard L, Miyajima K, Harada K, Ariyoshi Y, Takahashi T, Sugio K, Brambilla M. Gilcrease M, et al. DNA methylation profiles of lung tumors. Mol Cancer Ther 2001;1:61-7.
5. Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandwijk N, Mooi WJ, Bos JL, Rodenhuis S, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990;323:561-5.
6. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
7. Sridhar KS, Raub WA, Jr, Duncan RC, Hilsenbeck S. The increasing recognition of adenosquamous lung carcinoma (1977-1986). Am J Clin Oncol 1992;15:356-62.
8. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
9. Ishida T, Kaneko S, Yokoyama H, Inoue T, Sugio K, Sugimachi K. Adenosquamous carcinoma of the lung. Clinicopathologic and immunohistochemical features. Am J Clin Pathol 1992;97:678-85.
10. Niho S, Yokose T, Kodama T, Nishiwaki Y, Mukai K. Clonal analysis of adenosquamous carcinoma of the lung. Jpn J Cancer Res 1999;90:1244-7.
11. Kanazawa H, Ebina M, Ino-Oka N, Shimizukawa M, Takahashi T, Fujimura S, Imai T, Nukiwa T. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. Am J Pathol 2000;156:1289-98.
12. Graziano SL, Gamble GP, Newman NB, Abbott LZ, Rooney M, Mookherjee S, Lamb ML, Kohman LJ, Poiesz BJ. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer. J Clin Oncol 1999;17:668-75.
13. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-23.
14. Tokumo M, Toyooka S, Kiura K, Shigematsu H, Tomii K, Aoe M, Ishimura K, Tsuda T, Yano M, Tsukuda K, Tabata M, Ueoka H, et al. The relationship between epidermal growth factor receptor mutations and Clinicopathologic features in non-small cell lung cancers. Clin Cancer Res 2005;11:1167-73.